Reckitt Benckiser Group plc
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Kris Licht
- Full Time Employees
- 36,200
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- Turner House Slough BR United Kingdom SL1 3UH
- IPO Date
- Nov 7, 2007
- CIK
- 0001420798
- Website
- reckitt.com
- Similar Companies
- Business
- Reckitt Benckiser Group plc is a British multinational consumer goods company headquartered in Slough, United Kingdom, engaged in the manufacture and sale of health, hygiene, and nutrition products globally. Founded in 1999 through the merger of Reckitt & Colman plc and Benckiser NV, Reckitt organizes its business into three primary segments: Health, Hygiene, and Nutrition. Its Health segment includes over-the-counter (OTC) medicines, germ protection solutions, intimate wellness products, vitamins, minerals and supplements (VMS), and personal care items with flagship brands such as Mucinex, Strepsils, Gaviscon, Nurofen, and Biofreeze. The Hygiene segment covers surface and disinfection products, auto dishwash products, air care, fabric additives, lavatory care, and related categories with leading global brands including Lysol, Dettol, Harpic, Finish, and Vanish. The Nutrition segment offers infant and child nutrition products along with specialized nutritional solutions. Reckitt’s products are distributed across nearly 200 countries with a global network of distribution and embellishment centers. In major recent strategic developments, Reckitt has focused on sharpening its portfolio around high-growth and high-margin Powerbrands, divesting its Essential Home business, which includes home care brands like Cillit Bang and Calgon, to Advent International in 2025 while retaining a 30% equity stake, signaling a strategic shift toward a simpler, more focused consumer health and hygiene company. The company acquired the Biofreeze brand in 2021 to strengthen its presence in the pain relief category. Reckitt continues to drive innovation and market share growth in its core categories through product enhancements and sustained marketing investments, evidenced by strong growth in brands such as Lysol and Finish in 2024. These moves align with Reckitt’s strategy to focus on its top 19 most profitable brands, expected to generate 70% of net revenues, furthering its commitment to premium, high-growth segments with improved operational efficiency and shareholder value creation. Reckitt operates principally in the fast-moving consumer goods (FMCG) industry targeting retail consumers worldwide with a strong presence in the US, UK, China, and other key markets. The company employs over 35,000 people and maintains a robust global footprint with 131 distribution centers across 51 countries. Reckitt's strategic focus on health and hygiene, combined with its divestiture of non-core portfolios, positions the company to accelerate growth and margin expansion through leadership in consumer health, hygiene, and nutrition categories.
Company News
3 Cheap International Stocks to Buy
Reckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk
Reckitt Benckiser Group H1 Earnings Call Highlights
Reckitt launches £500m buyback as quarterly sales accelerate
Reckitt beats second-quarter sales estimates on emerging markets strength
Reckitt Benckiser sells one of its two Russian units
Jefferies upgrades Reckitt to buy, arguing market has over-punished transitory setbacks
Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula
Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth
Swiss bank sees upside for Reckitt Benckiser though the Dettol and Durex owner needs to "rebuild trust"
Reckitt stock dips on Q1 miss: what's really ailing the health giant?
Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance
Reckitt Benckiser Group plc (RBGLY) Presents at UBS Global Consumer and Retail Conference Transcript
Reckitt not yet rewarded for improved earnings model, says UBS after strong quarter
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript
Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress
Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets
Reckitt Benckiser Group (OTCMKTS:RBGPF) Stock Price Down 0.3% – What’s Next?
Reckitt downgraded by RBC as Deutsche Bank strikes more bullish tone
Reckitt to pay £1.6bn special dividend after Essential Home sale